BIXT
Price:
$0.0752
Market Cap:
$6.69M
Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was incorporated ...[Read more]
Industry
Biotechnology
IPO Date
2010-01-05
Stock Exchange
OTC
Ticker
BIXT
According to Bioxytran, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.53M. This represents a change of -7.62% compared to the average of 8.15M of the last 4 quarters.
The mean historical Enterprise Value of Bioxytran, Inc. over the last ten years is 23.40M. The current 7.53M Enterprise Value has changed 3.12% with respect to the historical average. Over the past ten years (40 quarters), BIXT's Enterprise Value was at its highest in in the June 2019 quarter at 84.85M. The Enterprise Value was at its lowest in in the September 2017 quarter at 421.15K.
Average
23.40M
Median
23.08M
Minimum
560.10K
Maximum
57.14M
Discovering the peaks and valleys of Bioxytran, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.42%
Maximum Annual Enterprise Value = 57.14M
Minimum Annual Increase = -69.57%
Minimum Annual Enterprise Value = 560.10K
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 13.55M | -38.51% |
| 2023 | 22.03M | -61.44% |
| 2022 | 57.14M | 28.25% |
| 2021 | 44.55M | 84.68% |
| 2020 | 24.12M | -3.48% |
| 2019 | 24.99M | -42.67% |
| 2018 | 43.59M | 1.42% |
| 2017 | 2.86M | 410.49% |
| 2016 | 560.10K | -2.36% |
| 2015 | 573.65K | -69.57% |
The current Enterprise Value of Bioxytran, Inc. (BIXT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
30.91M
5-year avg
32.28M
10-year avg
23.40M
Bioxytran, Inc.’s Enterprise Value is less than Glow Lifetech Corp. (9.39M), greater than Burzynski Research Institute, Inc. (5.78M), less than Theralink Technologies, Inc. (19.38M), greater than Kane Biotech Inc. (5.98M), greater than BioVaxys Technology Corp. (6.25M), greater than Mosaic ImmunoEngineering Inc. (5.39M), less than BetterLife Pharma Inc. (9.64M), less than ProText Mobility, Inc. (9.11M), greater than NanoSphere Health Sciences Inc. (86.50K), greater than MYND Life Sciences Inc. (6.35M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 9.39M | $7.21M | |
| 5.78M | $5.78M | |
| 19.38M | $615.15K | |
| 5.98M | $4.16M | |
| 6.25M | $4.54M | |
| 5.39M | $4.38M | |
| 9.64M | $8.85M | |
| 9.11M | $9.11M | |
| 86.50K | $42.13K | |
| 6.35M | $1.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioxytran, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bioxytran, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Bioxytran, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Bioxytran, Inc. (BIXT)?
What is the 3-year average Enterprise Value for Bioxytran, Inc. (BIXT)?
What is the 5-year average Enterprise Value for Bioxytran, Inc. (BIXT)?
How does the current Enterprise Value for Bioxytran, Inc. (BIXT) compare to its historical average?